Duyuru • Jun 11
Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion. Novanta Inc. (NasdaqGS:NOVT) entered into a definitive agreement to acquire Riverpoint Medical, LLC from Arlington Capital Partners V, L.P., a fund managed by Arlington Management Employees, LLC for $1.5 billion on June 8, 2026. A cash consideration of $1.2 billion will be paid by Novanta Inc. Novanta Inc. will pay a milestone payment of $250 million in the first quarter of 2027. Upon completion of the transaction, Riverpoint Medical will be reported under Novanta’s Medical Solutions operating segment. The transaction will be financed through a combination of cash on hand and Novanta’s existing credit facility, and the recently completed $300 million equity raise.
The transaction is subject to customary regulatory approvals and the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The transaction is expected to close in the third quarter of 2026. The transaction is expected to be immediately accretive in 2026 to Novanta’s Adjusted Diluted Earnings Per Share, and in 2027 accretive to revenue growth rate, Adjusted Gross and EBITDA Margins, Adjusted Diluted Earnings Per Share, and Operating Cash Flows.
Robert W. Baird & Co. Incorporated acted as financial advisor for Novanta Inc. Jefferies LLC acted as financial advisor for Riverpoint Medical, LLC. J.P. Morgan Securities LLC acted as financial advisor for Novanta Inc. King & Spalding LLP acted as legal advisor for Novanta Inc. Matthew J. Byron, Melissa Rones, Emily Karlberg, Renata Ferrari, Pamela Glazier, Samer Musallam, Lisa Kaltenbrunner, Emerson Siegle, Deidre Johnson, Ryan Murphey, Rebecca Liu, Heather Sprague, Alison McLaughlin, and Kurt Fowler of Ropes & Gray LLP acted as legal advisor for Novanta Inc. Joshua Klatzkin, Matthew M. Mauney, and Michael Amalfe of Goodwin Procter LLP acted as legal advisor for Riverpoint Medical, LLC. Duyuru • Jun 10
Novanta Inc. announced that it expects to receive $299.99998 million in funding Novanta Inc. entered into a Securities Purchase Agreement and announced a private placement of 2,142,857 Common Shares of the company at an issue price of $140 for gross proceeds up to $300.0 million on June 8, 2026. The transaction involves participation from institutional and other accredited investors. The private placement is expected to close on or about June 11, 2026, subject to satisfaction of customary closing conditions. Canlı Haberler • Jun 09
Novanta Expands Medical Consumables With US$1.2 Billion Riverpoint Deal and US$300 Million Capital Raise Novanta agreed to acquire Riverpoint Medical for US$1.2b in cash, with an additional US$250m contingent on performance milestones.
The Riverpoint deal is expected to expand Novanta’s presence in advanced surgical fibers and specialized devices, particularly minimally invasive surgical consumables across sports medicine, trauma and cardiovascular procedures.
Novanta previously announced a private placement of common stock to raise about US$300m from institutional and accredited investors, with proceeds earmarked for operational and growth investments.
Taken together, the Riverpoint acquisition and the earlier US$300m capital raise indicate a clear push to build out Novanta’s medical consumables footprint and support future growth projects.
Investors should watch for updates on regulatory approvals, integration progress once the deal closes, and any impact on the company’s balance sheet and share count from the cash outlay and equity issuance. Major Estimate Revision • May 18
Consensus EPS estimates increase by 15% The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate increased from US$2.16 to US$2.49. Revenue forecast steady at US$1.05b. Net income forecast to grow 102% next year vs 32% growth forecast for Electronic industry in the US. Consensus price target up from US$157 to US$172. Share price rose 9.3% to US$153 over the past week. Price Target Changed • May 13
Price target increased by 7.2% to US$172 Up from US$160, the current price target is an average from 2 analysts. New target price is 10% above last closing price of US$155. Stock is up 18% over the past year. The company is forecast to post earnings per share of US$2.49 for next year compared to US$1.47 last year. Reported Earnings • May 12
First quarter 2026 earnings: EPS and revenues exceed analyst expectations First quarter 2026 results: EPS: US$0.52 (down from US$0.59 in 1Q 2025). Revenue: US$257.7m (up 10% from 1Q 2025). Net income: US$21.1m (flat on 1Q 2025). Profit margin: 8.2% (down from 9.1% in 1Q 2025). Revenue exceeded analyst estimates by 1.7%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Revenue is forecast to grow 5.9% p.a. on average during the next 2 years, compared to a 13% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has only fallen by 1% per year, which means it has not declined as severely as earnings. Duyuru • May 12
Novanta Inc. Provides Earnings Guidance for the Second Quarter and Full Year of 2026 Novanta Inc. provided earnings guidance for the second quarter and full year of 2026. For the quarter, the company expects GAAP revenue to be in the range of $259 million to $264 million.
For the year, the company expects GAAP revenue to be in the range of $1,040 million to $1,055 million. Buy Or Sell Opportunity • Apr 20
Now 21% overvalued The stock has been flat over the last 90 days, currently trading at US$132. The fair value is estimated to be US$110, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 4.2% over the last 3 years. Earnings per share has declined by 11%. Revenue is forecast to grow by 13% in 2 years. Earnings are forecast to grow by 107% in the next 2 years. Duyuru • Apr 14
Novanta Inc. to Report Q1, 2026 Results on May 11, 2026 Novanta Inc. announced that they will report Q1, 2026 results at 4:00 PM, US Eastern Standard Time on May 11, 2026 Recent Insider Transactions Derivative • Mar 19
Chief Financial Officer exercised options and sold US$1.0m worth of stock On the 16th of March, Robert Buckley exercised 10k options at a strike price of around US$14.13 and sold these shares for an average price of US$117 per share. This trade did not impact their existing holding. Since June 2025, Robert's direct individual holding has increased from 127.25k shares to 132.84k. Company insiders have collectively sold US$3.8m more than they bought, via options and on-market transactions in the last 12 months. Major Estimate Revision • Mar 02
Consensus EPS estimates fall by 21% The consensus outlook for fiscal year 2026 has been updated. 2026 EPS estimate fell from US$2.72 to US$2.16 per share. Revenue forecast steady at US$1.04b. Net income forecast to grow 66% next year vs 28% growth forecast for Electronic industry in the US. Consensus price target up from US$154 to US$160. Share price fell 5.6% to US$134 over the past week. Recent Insider Transactions Derivative • Feb 27
CEO & Chairman of the Board exercised options and sold US$721k worth of stock On the 24th of February, Matthijs Glastra exercised options to acquire 5k shares at no cost and sold these for an average price of US$137 per share. This trade did not impact their existing holding. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since June 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 124.14k. Company insiders have collectively sold US$2.4m more than they bought, via options and on-market transactions in the last 12 months. Price Target Changed • Feb 25
Price target increased by 7.0% to US$160 Up from US$150, the current price target is an average from 2 analysts. New target price is 20% above last closing price of US$133. Stock is down 11% over the past year. The company is forecast to post earnings per share of US$2.16 for next year compared to US$1.47 last year. Reported Earnings • Feb 24
Full year 2025 earnings: EPS misses analyst expectations Full year 2025 results: EPS: US$1.47 (down from US$1.78 in FY 2024). Revenue: US$980.6m (up 3.3% from FY 2024). Net income: US$53.8m (down 16% from FY 2024). Profit margin: 5.5% (down from 6.8% in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.9%. Revenue is forecast to grow 6.5% p.a. on average during the next 2 years, compared to a 11% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 11% per year but the company’s share price has only fallen by 4% per year, which means it has not declined as severely as earnings. Duyuru • Feb 24
Novanta Inc. Provides Revenue Guidance for the First Quarter and for the Full Year 2026 Novanta Inc. provided revenue guidance for the first quarter and For the full year 2026. For the first quarter of 2026, the Company expects GAAP revenue to be in the range of $250 million to $255 million.
For the full year, the Company expects GAAP revenue to be in the range of $1,030 million to $1,050 million. Recent Insider Transactions Derivative • Feb 12
CEO & Chairman of the Board notifies of intention to sell stock Matthijs Glastra intends to sell 8k shares in the next 90 days after lodging an Intent To Sell Form on the 10th of February. If the sale is conducted around the recent share price of US$145, it would amount to US$1.1m. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 119.25k. Company insiders have collectively sold US$1.8m more than they bought, via options and on-market transactions in the last 12 months. Duyuru • Feb 10
Novanta Inc., Annual General Meeting, May 28, 2026 Novanta Inc., Annual General Meeting, May 28, 2026. Recent Insider Transactions Derivative • Feb 03
CEO & Chairman of the Board notifies of intention to sell stock Matthijs Glastra intends to sell 7k shares in the next 90 days after lodging an Intent To Sell Form on the 2nd of February. If the sale is conducted around the recent share price of US$135, it would amount to US$878k. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs' direct individual holding has decreased from 139.75k shares to 125.75k. Company insiders have collectively sold US$1.8m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions Derivative • Jan 22
Chief Financial Officer notifies of intention to sell stock Robert Buckley intends to sell 44k shares in the next 90 days after lodging an Intent To Sell Form on the 21st of January. If the sale is conducted around the recent share price of US$131, it would amount to US$5.8m. Since March 2025, Robert has owned 127.25k shares directly. Company insiders have collectively sold US$1.6m more than they bought, via options and on-market transactions in the last 12 months. Duyuru • Jan 22
Novanta Inc. to Report Q4, 2025 Results on Feb 24, 2026 Novanta Inc. announced that they will report Q4, 2025 results Pre-Market on Feb 24, 2026 Recent Insider Transactions Derivative • Jan 11
CEO & Chairman of the Board notifies of intention to sell stock Matthijs Glastra intends to sell 6k shares in the next 90 days after lodging an Intent To Sell Form on the 9th of January. If the sale is conducted around the recent share price of US$130, it would amount to US$803k. For the year to December 2019, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2025, Matthijs has owned 139.75k shares directly. Company insiders have collectively sold US$1.6m more than they bought, via options and on-market transactions in the last 12 months. Valuation Update With 7 Day Price Move • Nov 10
Investor sentiment deteriorates as stock falls 22% After last week's 22% share price decline to US$105, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 19x in the Electronic industry in the US. Total loss to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$46.01 per share. Duyuru • Nov 07
Novanta Inc. has completed a Composite Units Offering in the amount of $550 million. Novanta Inc. has completed a Composite Units Offering in the amount of $550 million.
Security Name: Units
Security Type: Debt/Equity Composite Units
Securities Offered: 11,000,000
Price\Range: $50
Discount Per Security: $1.375 Reported Earnings • Nov 04
Third quarter 2025 earnings: EPS misses analyst expectations Third quarter 2025 results: EPS: US$0.30 (down from US$0.53 in 3Q 2024). Revenue: US$247.8m (up 1.4% from 3Q 2024). Net income: US$10.7m (down 45% from 3Q 2024). Profit margin: 4.3% (down from 7.9% in 3Q 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 28%. Revenue is forecast to grow 6.6% p.a. on average during the next 2 years, compared to a 9.6% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 9% per year whereas the company’s share price has fallen by 4% per year. Duyuru • Nov 04
Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2025 and Fiscal Year 2026 Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2025 and fiscal year 2026. For the fourth quarter of 2025, the Company expects GAAP revenue of approximately $253 million to $257 million.
For the full year 2025, the Company expects GAAP revenue of approximately $975 million to $979 million.
Looking forward to full year 2026, the company now expects to deliver mid-single digit organic revenue growth as a result of continued momentum in business and end markets, the strength of new design wins, and new product launches. Valuation Update With 7 Day Price Move • Oct 26
Investor sentiment improves as stock rises 22% After last week's 22% share price gain to US$129, the stock trades at a forward P/E ratio of 60x. Average forward P/E is 21x in the Electronic industry in the US. Total loss to shareholders of 9.7% over the past three years. Duyuru • Oct 08
Novanta Inc. to Report Q3, 2025 Results on Nov 04, 2025 Novanta Inc. announced that they will report Q3, 2025 results Pre-Market on Nov 04, 2025 Duyuru • Sep 19
Novanta Inc. Announces the Resignation of Barbara Hulit as Member of the Board of Directors and the Audit Committee and Environmental, Social and Governance Committee of the Board, Effective November 1, 2025 Novanta Inc. announced that on September 15, 2025, Barbara Hulit resigned as a member of the Board of Directors of the company and the Audit Committee and Environmental, Social and Governance Committee of the Board, effective November 1, 2025. Ms. Hulit’s decision to resign was not because of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices. Major Estimate Revision • Aug 12
Consensus EPS estimates fall by 32% The consensus outlook for fiscal year 2025 has been updated. 2025 EPS estimate fell from US$2.53 to US$1.72 per share. Revenue forecast steady at US$975.6m. Net income forecast to grow 27% next year vs 30% growth forecast for Electronic industry in the US. Consensus price target down from US$150 to US$142. Share price rose 4.7% to US$121 over the past week. Reported Earnings • Aug 05
Second quarter 2025 earnings: Revenues exceed analysts expectations while EPS lags behind Second quarter 2025 results: EPS: US$0.13 (down from US$0.38 in 2Q 2024). Revenue: US$241.0m (up 2.2% from 2Q 2024). Net income: US$4.50m (down 67% from 2Q 2024). Profit margin: 1.9% (down from 5.8% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.3%. Earnings per share (EPS) missed analyst estimates by 76%. Revenue is forecast to grow 6.8% p.a. on average during the next 2 years, compared to a 8.1% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 5% per year whereas the company’s share price has fallen by 8% per year. Duyuru • Aug 05
Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year 2025 Novanta Inc. provided earnings guidance for the third quarter and full year 2025. For the quarter, the Company expects GAAP revenue of approximately $244 million to $247 million.
For the full year 2025, the Company expects GAAP revenue of approximately $970 million to $985 million. Duyuru • Jul 13
Novanta Inc. Announces Departure of Michele D. Welsh, General Counsel and Corporate Secretary, Effective on July 18, 2025 On July 8, 2025, Novanta Inc. (the Company) announced that Michele D. Welsh, General Counsel and Corporate Secretary of the Company, would no longer serve in those positions, effective on July 18, 2025, or such earlier date as may be agreed between Ms. Welsh and the Company. There are no changes to the severance that Ms. Welsh is entitled to receive pursuant to Section 4(a)(iv) of Ms. Welsh’s employment agreement dated July 11, 2022. Duyuru • Jul 09
Novanta Inc. to Report Q2, 2025 Results on Aug 05, 2025 Novanta Inc. announced that they will report Q2, 2025 results on Aug 05, 2025 Price Target Changed • May 12
Price target decreased by 9.4% to US$147 Down from US$163, the current price target is an average from 3 analysts. New target price is 12% above last closing price of US$132. Stock is down 19% over the past year. The company is forecast to post earnings per share of US$2.48 for next year compared to US$1.78 last year. Duyuru • May 07
Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million. Novanta Inc. (NasdaqGS:NOVT) acquired Keonn Technologies, S.L. for €60.6 million on April 8, 2025. A an initial cash payment of €60.6 million ($66.4 million), subject to customary closing and net working capital adjustments. The purchase includes up to €20.0 million ($21.9 million) in contingent consideration payable upon the achievement of certain revenue targets through December 2027. In addition, the Company has granted equity totaling €9.0 million ($9.9 million) to Keonn employees. The Keonn acquisition will be included in the Medical Solutions reportable segment. On April 8, 2025, Novanta drew down on revolving credit facility under the Senior Credit Facilities to fund the acquisition of Keonn Technologies, S.L. The acquisition was financed with cash on-hand and borrowings under Novanta's revolving credit facility.
Novanta Inc. (NasdaqGS:NOVT) completed the acquisition of Keonn Technologies, S.L. on April 8, 2025. Reported Earnings • May 07
First quarter 2025 earnings: EPS exceeds analyst expectations First quarter 2025 results: EPS: US$0.59 (up from US$0.41 in 1Q 2024). Revenue: US$233.4m (up 1.1% from 1Q 2024). Net income: US$21.2m (up 45% from 1Q 2024). Profit margin: 9.1% (up from 6.4% in 1Q 2024). The increase in margin was primarily driven by lower expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 44%. Revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 7.2% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has fallen by 1% per year and the company’s share price has also fallen by 1% per year. Duyuru • May 06
Novanta Inc. Provides Earnings Guidance for the Second Quarter of 2025 Novanta Inc. provided earnings guidance for the second quarter of 2025. For the quarter, the Company expects GAAP revenue of approximately $230 million to $240 million. Duyuru • Apr 28
Novanta Inc., Annual General Meeting, May 29, 2025 Novanta Inc., Annual General Meeting, May 29, 2025. Buy Or Sell Opportunity • Apr 24
Now 20% overvalued Over the last 90 days, the stock has fallen 19% to US$121. The fair value is estimated to be US$100, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 7.6% over the last 3 years, while earnings per share has been flat. Revenue is forecast to grow by 14% in 2 years. Earnings are forecast to grow by 76% in the next 2 years. Duyuru • Apr 09
Novanta Inc. to Report Q1, 2025 Results on May 06, 2025 Novanta Inc. announced that they will report Q1, 2025 results on May 06, 2025 Valuation Update With 7 Day Price Move • Apr 04
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to US$104, the stock trades at a forward P/E ratio of 43x. Average forward P/E is 16x in the Electronic industry in the US. Total loss to shareholders of 22% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at US$101 per share. Recent Insider Transactions Derivative • Feb 27
CEO & Chairman of the Board exercised options and sold US$726k worth of stock On the 24th of February, Matthijs Glastra exercised options to acquire 5k shares at no cost and sold these for an average price of US$138 per share. This trade did not impact their existing holding. For the year to December 2018, Matthijs' total compensation was 9% salary and 91% other compensation. This indicates that these sales could comprise a meaningful part of their income for the year. Since March 2024, Matthijs' direct individual holding has decreased from 148.84k shares to 134.15k. Company insiders have collectively sold US$7.7m more than they bought, via options and on-market transactions in the last 12 months. Duyuru • Feb 26
Novanta Inc. Provides Earnings Guidance for the First Quarter of 2025 and Full Year 2025 Novanta Inc. provided earnings guidance for the first quarter of 2025 and full year 2025. For the quarter, the company expects GAAP revenue of approximately $232 million to $236 million.
For the year, the company expects GAAP revenue of approximately $1.0 billion, representing revenue growth of approximately 5% year-over-year. Reported Earnings • Feb 25
Full year 2024 earnings: Revenues and EPS in line with analyst expectations Full year 2024 results: EPS: US$1.78 (down from US$2.03 in FY 2023). Revenue: US$949.2m (up 7.7% from FY 2023). Net income: US$64.1m (down 12% from FY 2023). Profit margin: 6.8% (down from 8.3% in FY 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) were also in line with analyst expectations. Revenue is forecast to grow 8.2% p.a. on average during the next 2 years, compared to a 7.4% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 2% per year whereas the company’s share price has increased by 4% per year. Duyuru • Jan 29
Novanta Inc. to Report Q4, 2024 Results on Feb 25, 2025 Novanta Inc. announced that they will report Q4, 2024 results on Feb 25, 2025 Price Target Changed • Dec 05
Price target decreased by 9.0% to US$165 Down from US$181, the current price target is an average from 3 analysts. New target price is approximately in line with last closing price of US$166. Stock is up 9.8% over the past year. The company is forecast to post earnings per share of US$1.76 for next year compared to US$2.03 last year. Recent Insider Transactions • Nov 14
CEO & Chairman of the Board recently sold US$1.3m worth of stock On the 11th of November, Matthijs Glastra sold around 8k shares on-market at roughly US$180 per share. This transaction amounted to 5.6% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. This was Matthijs' only on-market trade for the last 12 months. Reported Earnings • Nov 07
Third quarter 2024 earnings: EPS misses analyst expectations Third quarter 2024 results: EPS: US$0.53 (down from US$0.59 in 3Q 2023). Revenue: US$244.4m (up 10% from 3Q 2023). Net income: US$19.2m (down 9.6% from 3Q 2023). Profit margin: 7.9% (down from 9.6% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 3.6%. Revenue is forecast to grow 8.6% p.a. on average during the next 3 years, compared to a 7.3% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 6% per year whereas the company’s share price has increased by 3% per year. Recent Insider Transactions Derivative • Nov 06
Chief Financial Officer exercised options and sold US$582k worth of stock On the 1st of November, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$173 per share. This trade did not impact their existing holding. Since December 2023, Robert's direct individual holding has decreased from 121.56k shares to 120.42k. Company insiders have collectively sold US$5.6m more than they bought, via options and on-market transactions in the last 12 months. Duyuru • Nov 05
Novanta Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year of 2024 and Revenue Guidance for the Year 2025 Novanta Inc. provided earnings guidance for the fourth quarter and full year of 2024 and revenue guidance for the year 2025. For the fourth quarter of 2024, the company expects GAAP revenue of approximately $237 million to $242 million.
For the full year 2024, the company expects GAAP revenue of approximately $948 million to $953 million.
The company expects organic revenue growth of up to 10% in 2025 compared to 2024. Duyuru • Oct 09
Novanta Inc. to Report Q3, 2024 Results on Nov 05, 2024 Novanta Inc. announced that they will report Q3, 2024 results on Nov 05, 2024 Recent Insider Transactions Derivative • Oct 03
Chief Financial Officer notifies of intention to sell stock Robert Buckley intends to sell 27k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of October. If the sale is conducted around the recent share price of US$179, it would amount to US$4.9m. Since December 2023, Robert's direct individual holding has decreased from 121.56k shares to 120.42k. Company insiders have collectively sold US$4.5m more than they bought, via options and on-market transactions in the last 12 months. Recent Insider Transactions Derivative • Sep 06
Chief Financial Officer exercised options and sold US$710k worth of stock On the 3rd of September, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$176 per share. This trade did not impact their existing holding. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$4.3m more than they bought, via options and on-market transactions in the last 12 months. Duyuru • Aug 24
Novanta Inc. Announces Executive Changes On August 22, 2024, John Burke, formerly Vice President of Global Accounting for Novanta Inc. (company) was appointed Chief Accounting Officer of the company and assumed the role of principal accounting officer. Mr. Burke succeeds Peter Chang, Chief Accounting Officer and Corporate Controller of the Company, who departed from the role effective August 22, 2024. Mr. Chang, who served thirteen years in the role, will serve as an advisor to the Chief Financial Officer until his anticipated departure from the Company on February 28, 2025, and will assist with the transition of the Chief Accounting Officer role. Mr. Burke, age 43, has been it’s Vice President of Global Accounting since 2021, and previously served as Vice President of Accounting from 2017 to 2021 and Assistant Corporate Controller from 2011 to 2017. Prior to joining the company, Mr. Burke worked as the Manager of Technical Accounting and Reporting at MilliporeSigma (formerly known as Millipore Corporation), and prior to that, as an audit manager in the Boston office of PricewaterhouseCoopers LLP. Mr. Burke is a Certified Public Accountant and has a Bachelor of Business Administration degree in Accounting from the University of Massachusetts-Amherst. Reported Earnings • Aug 07
Second quarter 2024 earnings: EPS misses analyst expectations Second quarter 2024 results: EPS: US$0.38 (down from US$0.58 in 2Q 2023). Revenue: US$235.9m (up 2.8% from 2Q 2023). Net income: US$13.8m (down 34% from 2Q 2023). Profit margin: 5.8% (down from 9.1% in 2Q 2023). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 9.5%. Revenue is forecast to grow 12% p.a. on average during the next 2 years, compared to a 7.2% growth forecast for the Electronic industry in the US. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth. Duyuru • Aug 07
Novanta Inc. Provides Earnings Guidance for the Third Quarter and Full Year of 2024 Novanta Inc. provided earnings guidance for the third quarter and full year of 2024. For the quarter, Company expects GAAP revenue of approximately $241 millionto $244 million.
For the year, the company expects GAAP revenue of approximately $975 million, representing reported revenue growth of greater than 10%. Recent Insider Transactions Derivative • Aug 06
Chief Financial Officer exercised options and sold US$652k worth of stock On the 1st of August, Robert Buckley exercised 4k options at a strike price of around US$14.13 and sold these shares for an average price of US$173 per share. This trade did not impact their existing holding. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$3.3m more than they bought, via options and on-market transactions in the last 12 months. Buy Or Sell Opportunity • Aug 06
Now 26% overvalued after recent price rise Over the last 90 days, the stock has risen 7.3% to US$170. The fair value is estimated to be US$135, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 14% over the last 3 years. Earnings per share has grown by 18%. Revenue is forecast to grow by 12% in a year. Earnings are forecast to grow by 20% in the next year. Duyuru • Jul 10
Novanta Inc. to Report Q2, 2024 Results on Aug 06, 2024 Novanta Inc. announced that they will report Q2, 2024 results on Aug 06, 2024 Recent Insider Transactions Derivative • Jul 05
Chief Financial Officer notifies of intention to sell stock Robert Buckley intends to sell 22k shares in the next 90 days after lodging an Intent To Sell Form on the 1st of July. If the sale is conducted around the recent share price of US$163, it would amount to US$3.6m. Since September 2023, Robert's direct individual holding has decreased from 136.56k shares to 120.42k. Company insiders have collectively sold US$2.1m more than they bought, via options and on-market transactions in the last 12 months. 
